The Food and Drug Administration (FDA or the Agency) is reopening the comment period for the notice of availability for ``Development of a Shared System Risk Evaluation and Mitigation Strategy; Draft Guidance for Industry,'' published in the Federal Register of June 1, 2018. The Agency has received a request for an extension of the comment period for the draft guidance.
Document
Development of a Shared System Risk Evaluation and Mitigation Strategy; Draft Guidance for Industry; Availability; Reopening of the Comment Period
The Food and Drug Administration (FDA or the Agency) is reopening the comment period for the notice of availability for ``Development of a Shared System Risk Evaluation and Miti...
Legal Citation
Federal Register Citation
Use this for formal legal and research references to the published document.
83 FR 44273
Web Citation
Suggested Web Citation
Use this when citing the archival web version of the document.
“Development of a Shared System Risk Evaluation and Mitigation Strategy; Draft Guidance for Industry; Availability; Reopening of the Comment Period,” thefederalregister.org (August 30, 2018), https://thefederalregister.org/documents/2018-18775/development-of-a-shared-system-risk-evaluation-and-mitigation-strategy-draft-guidance-for-industry-availability-reopenin.